NanoViricides, Inc.

US$1.32As of Sun 8 Nov 2026, 12:00 UTC
AMEX:NNVCHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (26.58%)
Div yield —
ROE (101.46%)
Biotechnology
Beta (5Y) 1.83
PE TTM —
TSR TTM (20.48%)
Mkt cap US$33.69M
ROIC (64.09%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.62
22.51%
(58.83%)
Hold 1|5|6|11|7
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.02
0.02
0.02
0.03
22.38%
16.91%
15.48%
22.16%
Revenue$M
2.841
2.857
2.857
2.889
19.10%
14.02%
9.56%
6.73%
Peers (US$33.69M)
Cap (US$)
PE
35.03M
61.89x
34.75M
—
32.83M
—
33.87M
—
Capital
TTM
5Y
10Y
Leveragex
1.279
(1.084)
(0.830)
EBIT/Intx
0.185
0.193
0.255
Own earn%
(36.25)
(145.40)
(137.73)
Sh yield%
58.11
29.17
29.12
Owners
Insiders/Inst%
7.34
61.11
Short interest%
2.68
SBC / revenue%
5.21
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
8–13
$1 testx
0.0
Incr. ROIC%
3